Vorasidenib (AG-881) is a potent and selective, first-in-Class, brain-penetrant orally available inhibitor of mutated forms of both isocitrate dehydrogenase type 1 (IDH1, IDH1 [NADP+] soluble) in the cytoplasm and type 2 (IDH2, isocitrate dehydrogenase [NADP+], mitochondrial) in the mitochondria.
Molekulargewicht:
414.74
Reinheit:
99.58%
CAS Nummer:
[1644545-52-7]
Formel:
C14H13ClF6N6
Target-Kategorie:
Isocitrate Dehydrogenase (IDH)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
